Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 459

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia

Open access
Kim, Miriam Y., Yu, Kyung-Rok, Kenderian, Saad S., Ruella, Marco, Chen, Shirley, Shin, Tae-Hoon, Aljanahi, Aisha A., Schreeder, Daniel, Klichinsky, Michael, Shestova, Olga, Kozlowski, Miroslaw S., Cummins, Katherine D., Shan, Xinhe, Shestov, Maksim, Bagg, Adam, Morrissette, Jennifer J.D., Sekhri, Palak, Lazzarotto, Cicera R., Calvo, Katherine R., Kuhns, Douglas B., Donahue, Robert E., Behbehani, Gregory K., Tsai, Shengdar Q., Dunbar, Cynthia E., Gill, Saar·2018·Cell

Abstract

Summary The absence of cancer-restricted surface markers is a major impediment to antigen-specific immunotherapy using chimeric antigen receptor (CAR) T cells. For example, targeting the canonical myeloid marker CD33 in acute myeloid leukemia (AML) results in toxicity from destruction of normal myeloid cells. We hypothesized that a leukemia-specific antigen could be created by deleting CD33 from normal hematopoietic stem and progenitor cells (HSPC), thereby generating a hematopoietic system resistant to CD33-targeted therapy and enabling specific targeting of AML with CAR T cells. We generated CD33-deficient human HSPC and demonstrated normal engraftment and differentiation in immunodeficient mice. Autologous CD33 KO HSPC transplantation in rhesus macaques demonstrated long-term multilineage engraftment of gene-edited cells, with normal myeloid function. CD33-deficient cells were impervious to CD33-targeting CAR T cells, allowing for efficient elimination of leukemia without myelotoxicity. These studies illuminate a novel approach to antigen-specific immunotherapy by genetically engineering the host to avoid on-target, off-tumor toxicity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2018.05.013

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Cited by

See all 459

Metadata

Authors
Kim, M. Y., Yu, K.-R., Kenderian, S. S., Ruella, M., Chen, S., Shin, T.-H., Aljanahi, A. A., Schreeder, D., Klichinsky, M., Shestova, O., Kozlowski, M. S., Cummins, K. D., Shan, X., Shestov, M., Bagg, A., Morrissette, J. J. D., Sekhri, P., Lazzarotto, C. R., Calvo, K. R., Kuhns, D. B., Donahue, R. E., Behbehani, G. K., Tsai, S. Q., Dunbar, C. E., & Gill, S.
Venue
Cell
Publisher
Elsevier BV
Published
2018-05
Volume
173
Issue
6
Pages
1439-1453.e19
ISSN
0092-8674 (ISSN-L)
OpenAlex
W2805058565
Cited by
459
References
54
FWCI
16.09
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia. https://app.cochat.ai/papers/10.1016/j.cell.2018.05.013
The paper
Kim, M. Y., Yu, K.-R., Kenderian, S. S., Ruella, M., Chen, S., Shin, T.-H., Aljanahi, A. A., Schreeder, D., Klichinsky, M., Shestova, O., Kozlowski, M. S., Cummins, K. D., Shan, X., Shestov, M., Bagg, A., Morrissette, J. J. D., Sekhri, P., Lazzarotto, C. R., Calvo, K. R., . . . Gill, S. (2018). Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia. Cell. https://doi.org/10.1016/j.cell.2018.05.013

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.